Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

T. Brugat · SciRah

Researcher profile · Semantic Scholar

T. Brugat

Share profile

T. Brugat — researcher profile on SciRah

h-index: 10
Works: 29
Citations: 687

Most-cited papers

The role of the spleen in malaria
H. D. del Portillo, M. Ferrer, T. Brugat, L. Martín-Jaular +2 more
2012Cellular Microbiology199 citations Open access
Semantic Scholar
Vector transmission regulates immune control of Plasmodium virulence
P. Spence, W. Jarra, Prisca Lévy, A. Reid +5 more
2013Nature169 citations Open access
Semantic Scholar
Sequestration and histopathology in Plasmodium chabaudi malaria are influenced by the immune response in an organ-specific manner
T. Brugat, Deirdre Cunningham, Jan Sodenkamp, Stephanie M. Coomes +6 more
2013Cellular Microbiology74 citations Open access
Semantic Scholar
Antibody-independent mechanisms regulate the establishment of chronic Plasmodium infection
T. Brugat, A. Reid, Jing-wen Lin, Deirdre Cunningham +14 more
2017Nature Microbiology56 citations Open access
Semantic Scholar
Characterization of the Plasmodium Interspersed Repeats (PIR) proteins of Plasmodium chabaudi indicates functional diversity
Xue-Yan Yam, T. Brugat, A. Siau, J. Lawton +6 more
2016Scientific Reports39 citations Open access
Semantic Scholar
ICAM-1 is a key receptor mediating cytoadherence and pathology in the Plasmodium chabaudi malaria model
Deirdre Cunningham, Jing-wen Lin, T. Brugat, W. Jarra +5 more
2017Malaria Journal35 citations Open access
Semantic Scholar
Telomere dysfunction-induced foci arise with the onset of telomeric deletions and complex chromosomal aberrations in resistant chronic lymphocytic leukemia cells.
T. Brugat, F. Nguyen-Khac, A. Grelier, H. Merle-Béral +1 more
2010Blood34 citations
Semantic Scholar
Characterization and gene expression analysis of the cir multi-gene family of plasmodium chabaudi chabaudi (AS)
J. Lawton, T. Brugat, Yam-Xue Yan, A. Reid +8 more
2012BMC Genomics26 citations Open access
Semantic Scholar
Mosquitoes Reset Malaria Parasites
P. Spence, T. Brugat, J. Langhorne
2015PLoS Pathogens21 citations Open access
Semantic Scholar
Concomitant heterochromatinisation and down-regulation of gene expression unveils epigenetic silencing of RELB in an aggressive subset of chronic lymphocytic leukemia in males
J. Marteau, O. Rigaud, T. Brugat, N. Gault +7 more
2010BMC Medical Genomics16 citations Open access
Semantic Scholar
Characterization and gene expression analysis of the cir multi-gene family of plasmodium chabaudi chabaudi (AS)
J. Lawton, T. Brugat, Yam-Xue Yan, A. Reid +8 more
2012BMC Genomics8 citations Open access
Semantic Scholar
Concomitant telomere shortening, acquisition of multiple chromosomal aberrations and in vitro resistance to apoptosis in a single case of progressive CLL.
T. Brugat, F. Nguyen-Khac, H. Merle-Béral, J. Delic
2011Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis3 citations
Semantic Scholar
Abstract 3276: Clinical PK, PD and safety analysis of a phase I clinical trial of DT-9081, an EP4R-antagonist, for RP2D determination in patients with advanced solid tumours
C. le Tourneau, Z. Castel-Ajgal, J. Machiels, R. Galot +14 more
2025Cancer Research2 citations
Semantic Scholar
Targeting PAR-2 with a negative allosteric modulator increases tumor antigen presentation and potentiates anti-PD-1 immunotherapy
Samya Aouad, M. Kadiri, D. Allard, Emma Skora +14 more
2026Journal for ImmunoTherapy of Cancer1 citations Open access
Semantic Scholar
Abstract 312: Comprehensive characterization of DT-7012, a differentiated CCR8-depleting antibody for the treatment of solid tumors
Hélène Lelièvre, Mélanie Frauli, M. D. García Fernández, Dounia Chraa +11 more
2025Cancer Research1 citations
Semantic Scholar
Abstract B009: Targeting PAR-2 improves tumor antigen presentation and primes the immune system for anti-PD-1 immunotherapy
Samya Aouad, M. Kadiri, Lucie Giraud, Emma Skora +4 more
2025Cancer immunology research1 citations
Semantic Scholar
ICAM-1 is a key receptor mediating cytoadherence and pathology in the Plasmodium chabaudi malaria model
Deirdre Cunningham, Jing-wen Lin, T. Brugat, W. Jarra +5 more
2017Malaria Journal1 citations Open access
Semantic Scholar
Editorial: CD36: Russian roulette of host and parasites during malaria infection
T. Brugat
2016Journal of Leukocyte Biology1 citations
Semantic Scholar
Abstract 5239: Biomarker dynamics in the completed phase I study of DT-9081: An analysis of ex vivo cytokine stimulation, urinary PGEM, and tumoral biomarkers in advanced solid tumors
T. Maurin, Lola Lecru, Antoine Mousson, Orphée Blanchard +24 more
2026Cancer Research0 citations
Semantic Scholar
Abstract 4356: Comprehensive characterization of DT-7012, a highly differentiated anti-CCR8 depleting antibody
M. D. García Fernández, C. Franchet, L. Baron, Solène Rose +8 more
2026Cancer Research0 citations
Semantic Scholar
Abstract 2020: Fibroblast derived type III collagen pro-peptides (PRO-C3) in plasma is associated with outcome for patients with NSCLC treated with anti-PD1 plus chemotherapy
N. Willumsen, Lola Lecru, T. Brugat, John Stagg +2 more
2025Cancer Research0 citations
Semantic Scholar
Abstract 6157: PAR2 inhibitors reduce resistance to immunotherapy against cancer
T. Brugat, M. Kadiri, Samya Aouad, D. Allard +9 more
2025Cancer Research0 citations
Semantic Scholar
1324 Characterization of DT-7012, a highly differentiated anti-CCR8 mAb clinical candidate
Dounia Chraa, M. D. García Fernández, Alice Gentil Dit Maurin, I. Richert +15 more
2024Regular and Young Investigator Award Abstracts0 citations Open access
Semantic Scholar
Abstract 684: DT-9045, a novel PAR2 inhibitor with best-in-class properties that reduces resistance to both EGFR-targeting therapies and immunotherapy in oncology models
T. Brugat, M. Kadiri, Samya Aouad, Anne-Laure Blayo +17 more
2024Cancer Research0 citations
Semantic Scholar
Abstract 4961: Novel biased PAR2 inhibitors with best-in-class properties reduce resistance to both chemotherapy and immunotherapy in oncology models
T. Brugat, Francesco Bergami, B. Rugeri, Aurélie Janvier +18 more
2023Cancer Research0 citations
Semantic Scholar
OP0236 RELEVANCE OF BIASED PAR2 INHIBITORS IN REDUCING INFLAMMATION AND CARTILAGE DEGRADATION IN IN VITRO AND IN VIVO MODELS OF RHEUMATOID ARTHRITIS
T. Brugat, B. Rugeri, G. Hommet, A. Dumont +12 more
2020Annals of the Rheumatic Diseases0 citations Open access
Semantic Scholar
Explorer Antibody-independent mechanisms regulate the establishment of chronic Plasmodium infection
T. Brugat, A. Reid, Jing-Wen Lin, Deirdre Cunningham +15 more
20180 citations
Semantic Scholar
Explorer Mosquitoes reset malaria parasites
P. Spence, T. Brugat, J. Langhorne
20170 citations
Semantic Scholar
Dysfonction télomérique dans les cellules résistantes de leucémie lymphocytaire chronique (LLC)
T. Brugat
20100 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Schann×11
Invite
S. Schann — researcher profile on SciRah
J. Langhorne×10
Invite
J. Langhorne — researcher profile on SciRah
L. Baron×9
Invite
L. Baron — researcher profile on SciRah
N. Lenne×8
Invite
N. Lenne — researcher profile on SciRah

×8

Invite

C. Franchet — researcher profile on SciRah

Deirdre Cunningham×7

Invite

Deirdre Cunningham — researcher profile on SciRah

Aurélie Janvier×7

Invite

Aurélie Janvier — researcher profile on SciRah

Invite

P. Spence — researcher profile on SciRah

Anne-Laure Blayo×6

Invite

Anne-Laure Blayo — researcher profile on SciRah

Orphée Blanchard×6

Invite

Orphée Blanchard — researcher profile on SciRah

Invite

A. Reid — researcher profile on SciRah

Invite

M. Berriman — researcher profile on SciRah